Merck Announces a New Covid PillBy Radiant Health
Published: October 3, 2021
Health News Briefs
The pharmaceutical company Merck announced it would soon seek emergency use authorization for its new pill, molnupiravir, to treat Covid-19. In studies conducted on people who recently contracted the virus, the experimental drug cut hospitalizations and deaths in half. The pill must be taken within five days of the appearance of symptoms, and it did not appear to help those who are already severely ill.
Download your free digital edition of Radiant at radianthealthmag.com/free.
- Some Americans Will Have Medical Debt Wiped From Credit - July 9, 2022
- Natural Gas Used to Heat Homes Contains Some Harmful Chemicals - July 9, 2022
- Uterine Cancer Claims Many Black Lives - July 9, 2022
- Babies and Toddlers Get COVID-19 Shots - June 27, 2022
- FDA Bans Juul’s E-Cigarettes and Cartridges - June 27, 2022
- Polio Virus Found in London Sewage - June 27, 2022
- 200 Million Americans Are Drinking Contaminated Water - June 19, 2022
- Young Kids Can Finally Get Vaccinated Against COVID-19 - June 19, 2022
- New Regulations for Baby Sleep Products - June 19, 2022
- FDA Approves First Drug for Alopecia Hair Loss - June 19, 2022